Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pantetheine pathway enzymes are a group of enzymes vital to the biosynthesis of coenzyme A (CoA) from pantothenic acid (vitamin B5). This pathway involves phosphorylation, condensation with cysteine, decarboxylation, adenylylation, and final phosphorylation, each catalyzed by a distinct enzyme. These enzymes are essential for the formation of CoA, which is a cofactor in hundreds of metabolic reactions, especially in energy metabolism, fatty acid synthesis, and carboxylic acid activation. Due to the differences in the biosynthetic pathway between microbes and humans, several of these enzymes are attractive targets for antimicrobial drug development. However, "Pantetheine pathway enzyme" is a non-specific descriptor and should be clarified to refer to a specific enzyme in this pathway for precise scientific communication[1][2][3][5][6].
Competitive or allosteric inhibition of enzyme activity (e.g., blocking substrate binding or mimicking regulatory feedback, as CoA is a feedback inhibitor)[2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pantetheine pathway enzyme.